Device Market Trends | National Release, Future Pattern of Cardiovascular and Cancer Early Screening

On November 15, 2023, the National Health Commission, the National Development and Reform Commission and other departments issued the implementation plan for the prevention and control of cardiovascular and cerebrovascular diseases and cancer, many of which will directly affect the future device market pattern.

The premature mortality rate of major chronic diseases in China has decreased from 18.5% in 2015 to 15.2% in 2022, and the Healthy China Action – Implementation Plan of Cardiovascular and cerebrovascular Disease Prevention and Control Action (2023-2030)” and Healthy China Action – Implementation Plan of Cancer Prevention and Control Action (2023-2030)are clear. It is necessary to provide support and guarantee for the prevention and treatment of cancer and cardiovascular and cerebrovascular diseases from the source.

According to the Implementation Plan of the Healthy China Action on the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (2023-2030)， the state has included the prevention and treatment of cardiovascular and cerebrovascular diseases in important policy documents such as the Outline of the Healthy China 2030 Plan and China’s Medium and Long-Term Plan for the Prevention and Treatment of Chronic Diseases (2017-2025). And in the Healthy China Action (2019-2030)” 15 special actions set up “cardiovascular and cerebrovascular disease prevention and control action.”

The plan is clear: By 2030, a nationwide comprehensive prevention and control and early diagnosis and treatment system for cardiovascular and cerebrovascular diseases will be established; The ability and quality of the prevention and treatment of cardiovascular and cerebrovascular diseases in medical and health institutions at all levels have been further improved, great breakthroughs have been made in the prevention and treatment of cardiovascular and cerebrovascular diseases, and the death rate of cardiovascular and cerebrovascular diseases has dropped below 190.7 per 100,000 people.

The new cardiovascular and cerebrovascular disease prevention and implementation program released this time makes it clear that it is necessary to “implement the control of risk factors to reduce the risk of morbidity and mortality” and “strengthen the forward movement of the gateway and innovate the pathway of simultaneous prevention and treatment of cardiovascular and cerebrovascular diseases”. The program also aims to strengthen the management of blood pressure, blood glucose and blood lipids in primary healthcare institutions.

By 2030, the grassroots standardized management and service rate of hypertension and diabetes patients will reach 70%, the treatment rate and control rate will continue to increase on the basis of 2018, and the annual blood lipid detection rate of residents over 35 years old will reach 35%.To explore the secondary prevention and rehabilitation of patients with coronary heart disease and stroke into the scope of contracted services of family doctors.

The new Cancer Prevention and Control Implementation Program puts forward seven key areas of work: controlling risk factors to reduce the risk of cancer; improving the cancer prevention and treatment service system and strengthening information sharing; promoting early diagnosis and treatment of cancer and strengthening the long-term mechanism of screening; standardizing cancer diagnosis and treatment and upgrading the level of management and service; promoting the innovation of combining traditional Chinese and Western medicines and giving full play to the unique role of traditional Chinese medicines; strengthening the relief and rescue treatment and safeguard, and alleviating the burden of people’s medical treatment; accelerating the major scientific and technological researches, and promoting the transformation of innovative achievements.

Specific content includes: by 2030, all stroke centres in hospitals above the second level will carry out intravenous thrombolysis. Conditional places will establish chest pain and stroke “first aid maps” to effectively improve the efficiency of rescue and treatment. Promoting full coverage of medical quality control centres for cardiovascular and cerebrovascular diseases at the local and municipal levels and extending them to more than 50 per cent of counties.

Healthy China Action – Cancer Prevention Action Plan (2023-2030)”

The top five cancers in China are lung cancer, colorectal cancer, stomach cancer, liver cancer and breast cancer. By 2022, the early diagnosis rate of key cancer types in high-incidence areas in China has reached more than 55%.

The plan is clear that in the future, it is necessary to strengthen major source innovation and disruptive technological innovation in the prevention and control of chronic diseases and lead the prevention and control technology to make original breakthroughs. In view of the high incidence of cancer in China, focus on research and development of new cancer screening and early diagnosis and treatment technology.

It specifically covers a series of detailed deployments on the construction of cancer prevention and control institutions, the early screening industry, and the industrialization of scientific research achievements:

1. Building of cancer prevention and control institutions

The new program makes it clear that it is necessary to further strengthen the capacity building of cancer prevention and treatment institutions, and to improve the cancer prevention and treatment network at the national-provincial-prefecture-municipality-county level. It promotes the establishment and construction of national regional medical centres, focusing on oncology specialties, and improves the cancer prevention and treatment capacity of the central and western regions and grass-roots level through the synergy of many parties, including CDC institutions.

At the county level, the plan calls for strengthening the construction of tumor specialties in county-level hospitals and improving the level of cancer prevention and control through technical assistance. At the same time, cancer hospitals with strong professional technology are encouraged to carry out technical assistance in areas with insufficient resources to improve the overall cancer prevention and control ability.

Qualified secondary and above hospitals set up oncology departments, which can carry out cancer screening and general diagnosis and treatment of common multiple cancer types.

 2.New windfall in the early cancer screening industry

The plan clearly promotes early diagnosis and treatment of cancer and strengthens the long-term mechanism of screening. All regions will gradually expand the coverage of screening and early diagnosis and treatment, optimize the screening management model, support county-level hospitals to build “cancer screening and early diagnosis and treatment centers”, and improve the capacity of early screening and early diagnosis and treatment.

Cancer early screening has become a hot spot in the industry, according to the data of Zhiyanzhan Industrial Research Institute, the market size of China’s cancer early screening industry is expected to reach 9.357 billion yuan in 2025.

 3.Promoting the industrialization of scientific research results

The plan defines detailed arrangements for research and development, payment and other aspects in the field of cancer prevention and control.
For the cancer early screening industry, the plan encourages domestic enterprises to innovate, accelerate the application of basic frontier research results in the clinical and health industry, and promote breakthroughs in cancer vaccines, immunotherapy technology, and biological therapy technology.
The new program also requires the timely settlement of healthcare Security benefits for cancer patients in accordance with regulations, encourages commercial insurance institutions to develop commercial health insurance products related to cancer prevention and treatment, and guides public welfare and charitable organizations to actively carry out medical support for cancer patients.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source：Saibolan Device

Translated & edited：Bradyknow